Thursday, September 30, 2021

AlleyWatch

AlleyWatch

Alloy Raises $100M For its Identity Verification and Transaction Monitoring Platform for the Financial Services Industry

Posted: 30 Sep 2021 08:27 AM PDT

Know Your Customer (KYC) and Anti-Money Laundering (AML) requirements typically require financial institutions to rely on numerous third-party data providers for both onboarding and ongoing monitoring. Digitally-focused financial providers (neo-banks, fintech startups, global banks, and platform banks) face the decision to build systems in-house, a resource-intensive process, or rely on third-party integrations that are available in order to be compliant. Alloy, a complete identity decisioning and monitoring platform, makes that decision easy with its infrastructure-as-a-service platform. Launched in 2015, the company streamlines the onboarding process aided with automation and supports the customer lifecycle with ongoing monitoring to flag potential fraud and minimize risk. Alloy integrates with 120+ sources to ensure that its customers are able to build a complete and accurate picture of their customers and their financial transactions. The company has 200+ clients and has tripled its revenue in the last year. AlleyWatch caught up with Alloy Cofounder and CRO Laura Spiekerman to learn more about NYC's newest unicorn, how streamlining identity decisioning and monitoring spurs innovation in digital finance, the company's strategic plans, latest round of funding from investors that include Lightspeed Venture, Canapi Ventures, Bessemer Venture Partners, Avid Ventures, and Felicis Ventures.

Journey Clinic Raises $3M for its Service That Empowers Psychotherapists to Prescribe Psychedelics for Treatment

Posted: 30 Sep 2021 07:27 AM PDT

There has been a resurgence in the debate about the clinical use of Psychedelic therapies or psychedelic-assisted psychotherapy (PAP). There's been increased legalization of substances and ketamine has been the most-studied psychedelic drug for its promising response to treating mental health conditions especially when it comes to healing patients from past trauma. Journey Clinical is a prescription service that allows Psychotherapists to prescribe ketamine-assisted psychotherapy to unlock a new care pathway for patients for whom traditional pharmacological routes have not worked. Psychedelics are said to increase suggestibility, making patients more open to concepts brought up in therapy as well as resulting in neurotransmitter changes causing an improvement in mood. AlleyWatch caught up with Journey Clinic CEO Jonathan Sabbagh to learn more about the company's mission to make psychedelic therapy more accessible and mainstream, how his personal journey overworked in finance led the AHA moment, strategic plans, latest round of funding from investors that include Fifty Years Neo Kuma Ventures, Palo Santo, PsyMed Ventures, and Lionheart Ventures.

The Falling Giant: What the Evergrande Crisis Could Mean for Retail Investors

Posted: 30 Sep 2021 05:27 AM PDT

Evergrande has rarely strayed from newspaper headlines for all the wrong reasons throughout 2021. At the beginning of the year, investor panic was sparked by the container ship Ever Given as the vessel became stuck in the Suez Canal - causing jitters across global energy markets and international trade. Today, markets have been rocked by the prospect of a default by the Chinese real estate giants. But what could the collapse of Evergrande mean for the wider stock market and retail investors?

Don’t Rush into Your Second Act

Posted: 29 Sep 2021 04:27 AM PDT

I just wrapped up my last startup and I'm totally ready to take on the next one! I just had this great idea 5 seconds ago and I'm running with it! If I just had a good outcome on my first run as a Founder, my second one should be even better, right?
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

guest post needed

Hi I hope you're doing well. I'm reaching out to discuss the possibility of publishing articles on your website. Along with guest ...